Percutaneous coronary intervention versus optimal medical therapy for stable coronary artery disease: An umbrella review

Percutaneous coronary intervention versus optimal medical therapy for stable coronary artery disease: An umbrella review

Background: Invasive management of stable coronary artery disease is still a controversial topic. The purpose of this umbrella review was to synthesize systematic reviews (SRs) that evaluate the benefits and harms of percutaneous coronary intervention (PCI) versus optimal medical therapy (OMT) in pa...

Full description

Bibliographic Details
Main Authors:	David R. Soriano-Moreno, Daniel Fernandez-Guzman, Kimberly G. Tuco, Anderson N. Soriano-Moreno, Fabricio Ccami-Bernal, Abdiel H. Coico-Lama, Antony G. Gonzáles-Uribe, Alvaro Taype-Rondan
Format:	Article
Language:	English
Published:	Elsevier 2024-03-01
Series:	Heliyon
Subjects:	Percutaneous coronary intervention Optimal medical treatment Stable Angina
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024032419

Similar Items

Ivabradinum supplements the clinical efficacy of percutaneous coronary intervention in patients with coronary heart disease with stable angina
by: D. M Aronov, et al.
Published: (2017-06-01)

Nicorandil in patients with acute coronary syndrome and stable angina undergoing percutaneous coronary intervention: literature review
by: Neda Partovi, et al.
Published: (2015-01-01)

Nicorandil in patients with acute coronary syndrome and stable angina undergoing Percutaneous Coronary Intervention: literature review
by: Neda Partovi, et al.
Published: (2014-12-01)

Medical angioplasty for iatrogenic malignant coronary atherosclerosis
by: Kudel Kunhali, et al.
Published: (2017-01-01)

Intracoronary Adenosine to Prevent Myonecrosis in Patients with Stable Angina Undergoing Percutaneous Interventions: A Double-Blinded Randomized Controlled Trial
by: HamidReza Sanati, et al.
Published: (2015-10-01)

Rates of Elective Percutaneous Coronary Intervention in England and Wales: Impact of COURAGE and ORBITA Trials
by: Muhammad Rashid, et al.
Published: (2022-09-01)

The Role of Ranolazine for the Treatment of Residual Angina beyond the Percutaneous Coronary Revascularization
by: Simone Calcagno, et al.
Published: (2020-07-01)

Effect of preinfarction angina on primary percutaneous coronary intervention outcomes
by: Hamid Reza Sanati, et al.
Published: (2018-01-01)

PERCUTANEOUS INTERVENTION IN STABLE ANGINA: WHAT ISSUES DO WE SOLVE?
by: Yu. A. Karpov, et al.
Published: (2018-04-01)

THE ROLE OF PULSE REDUCTION THERAPY IN ADDITIONAL IMPROVEMENT OF CLINICAL EFFECTS OF MYOCARDIAL REVASCULARIZATION IN CORONARY HEART DISEASE STABLE ANGINA PATIENTS
by: D. M. Aronov, et al.
Published: (2018-06-01)

CARDIOPROTECTION POTENTIAL IN CORONARY HEART DISEASE TREATMENT
by: N. A. Shostak, et al.
Published: (2009-12-01)

Troponin I elevation after elective percutaneous coronary interventions: Prevalence and risk factors
by: Roberto Muniz Ferreira, et al.
Published: (2017-05-01)

Clinical characteristics and outcome of percutaneous coronary intervention in Yemeni patients
by: Taha AL-Maimoony, et al.
Published: (2023-01-01)

Four-year outcomes after percutaneous coronary intervention of unprotected left main coronary artery disease in patients with stable angina and acute coronary syndrome
by: Predescu Lucian, et al.
Published: (2021-06-01)

PERIOPERATIVE COMPLICATIONS AND REMOTE RESULTS OF PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH STABLE ANGINA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: V. K. ZAFIRAKI, et al.
Published: (2017-12-01)

Does anxiety cause angina recurrence after percutaneous coronary intervention in patients with STEMI?
by: Zhipeng Zhang, et al.
Published: (2023-10-01)

Predicting Residual Angina After Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from the OPEN‐CTO Registry
by: Neel M. Butala, et al.
Published: (2022-05-01)

Ranolazine: Multifaceted role beyond coronary artery disease, a recent perspective
by: Gopal Chandra Ghosh, et al.
Published: (2018-01-01)

Higher serum total bilirubin predicts high risk of 3-year adverse outcomes in patients undergoing primary percutaneous coronary intervention
by: Gao F, et al.
Published: (2019-07-01)

Prognostic significance of small vessel coronary artery disease in patients with acute coronary syndromes treated with percutaneous coronary interventions
by: Zofia Kampka, et al.
Published: (2023-02-01)

Interim analysis report of kuanxiong aerosol in improving angina and quality of life after percutaneous coronary intervention
by: Luo-Qi Lin, et al.
Published: (2022-01-01)

LEVELS OF INTERLEUKINS AND MELATONIN IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: M. A. Shalenkova, et al.
Published: (2014-11-01)

Advantages of percutaneous coronary intervention in relation to medication therapy in patients with stable angina pectoris ( three-wessel coronary disease)
by: Milićević Nemanja, et al.
Published: (2018-01-01)

Relationship between high-sensitivity C-reactive protein serum levels and the severity of coronary artery stenosis in patients with coronary artery disease
by: Seyed Masoud Seyedian, et al.
Published: (2016-12-01)

The relationships between acetylcholine-induced chest pain, objective measures of coronary vascular function and symptom status
by: Steven E. S. Miner, et al.
Published: (2023-08-01)

Acute effect of sildenafil on myocardial ischemic territories in patients with stable coronary artery disease
by: Mohamed Salem, et al.
Published: (2014-03-01)

OBSERVATIONAL MULTICENTER TRIAL OF NICORANDIL USE IN STABLE CORONARY HEART DISEASE HIGH RISK PATIENTS (NIKEA): DESIGN AND FIRST RESULTS
by: S. Yu. Martsevich, et al.
Published: (2017-10-01)

To Defer or Not Defer? The Challenges of Physiology in Acute Coronary Syndromes
by: Carlos M. Campos, et al.

A New Biomarker in The Distinction Between Stable Coronary Artery Disease and Acute Coronary Syndrome:Thiols
by: Fatih Balcı, et al.
Published: (2022-07-01)

Percutaneous coronary intervention provided better long term results than optimal medical therapy alone in patients with chronic total occlusion: A meta-analysis
by: Dibbendhu Khanra, et al.
Published: (2020-07-01)

Mesenteric angina successfully treated by percutaneous angioplasty
by: Ahoury N'guessan Judicael, Dr, et al.
Published: (2021-09-01)

Update on Coronary Angiography-Based Physiology Technologies
by: Alexandre Hideo-Kajita, et al.

An observational study to assess the outcomes of treatment of patients with stable angina after planned percutaneous coronary intervention: baseline patient characteristics
by: L. G. Ratova, et al.
Published: (2018-12-01)

Danhong injection improves elective percutaneous coronary intervention in ua patients with blood stasis syndrome revealed by perioperative metabolomics
by: Qian Niu, et al.
Published: (2022-01-01)

CYTOPROTECTOR MILDRONATE IN CORRECTING MYOCARDIAL DYSFUNCTION AMONG STABLE ANGINA PATIENTS AFTER CORONARY REVASCULARISATION
by: I. G. Gordeev, et al.
Published: (2009-04-01)

Cardiac shock-wave therapy in the treatment of coronary artery disease: systematic review and meta-analysis
by: Greta Burneikaitė, et al.
Published: (2017-04-01)

Impact of clinical presentation and presence of coronary sclerosis on long-term outcome of patients with non-obstructive coronary artery disease
by: Christine K. Kissel, et al.
Published: (2018-08-01)

Meta-analysis of Nicorandil effectiveness on myocardial protection after percutaneous coronary intervention
by: Xiao-Tao Zhao, et al.
Published: (2019-06-01)

Hyperhomocysteinemia and inflammatory biomarkers are associated with higher clinical SYNTAX score in patients with stable coronary artery disease
by: Đurić Predrag, et al.
Published: (2021-01-01)

Self-care as the Basis of the Mobile Application for Patients with Chronic Coronary Syndromes
by: A. I. Laskova, et al.
Published: (2022-07-01)